NL-OMON35025
已完成
不适用
A Randomized Clinical Trial to Study Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects - ketogenesis and glucose -dependent insulin secretion methodologies
Merck Sharp & Dohme (MSD)0 个研究点目标入组 12 人待定
适应症anti-obesity
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- anti-obesity
- 发起方
- Merck Sharp & Dohme (MSD)
- 入组人数
- 12
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •18\-45 years,
- •BMI 27\-35 kg/m2 (inclusive)
排除标准
- •Suffering from: hepatitis B, cancer or HIV/Aids. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1\.5 liters blood in the 10 months preceding the start of the study.
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Ketogenic diet treatment of epilepsy in infantsEUCTR2013-002195-40-GBniversity College London
已完成
不适用
Effect of ketocal formula on the seizureEpilepsy.Episodic and paroxysmal disordersG40 EpilepIRCT201210016907N5TRICIA30
招募中
不适用
Electroconvulsive therapy versus ketamine for improving symptoms in treatment resistant depressioHealth Condition 1: F332- Major depressive disorder, recurrent severe without psychotic featuresCTRI/2020/01/022914All India Institute of Medical Sciences New Delhi
招募中
不适用
Ketogenic and Nutritional Interventions for First Episode Bipolar DisorderBipolar I DisorderPsychosisSchizoaffective DisorderNCT06221852Mclean Hospital50
尚未招募
不适用
Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic ProfilingSchizophreniaSchizophrenia and Related DisordersBipolar DisorderBipolar and Related DisordersMajor Depressive DisorderMajor Depression SevereKetogenic DietingKetosisMetabolic DiseaseMetabolic SyndromeNCT06748950Stanford University120